• 

  Nepal grants emergency use approval to Bharat Biotech's Covaxin

  World | March 20, 2021 13:21 IST

  Bharat Biotech had applied for emergency use authorisation for its vaccine candidate, Covaxin, in Nepal on January 13. Covaxin demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials India.

• 

  HC asks Serum Institute, Bharat Biotech to disclose capacity to manufacture COVID-19 vaccines

  India | March 04, 2021 14:49 IST

  The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against COVID-19 currently as under the present system those above the age of 60 years or between 45 to 60 years with comorbidities can receive vaccination.

• 

  COVAXIN shows interim efficacy of 81% in phase 3 clinical trials

  India | March 03, 2021 17:41 IST

  India's indigenously developed vaccine against coronavirus COVAXIN has demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR, informed vaccine maker Bharat Biotech.

• 

  Chinese hackers target Indian Covid19 vaccine makers SII and Bharat Biotech : Report

  News | March 02, 2021 7:20 IST

  A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country's immunisation campaign, cyber intelligence firm Cyfirma told Reuters.

• 

  Chinese hackers target Indian vaccine makers Serum Institute, Bharat Biotech: Report

  India | March 01, 2021 23:33 IST

  Chinese and Russian-linked hacking campaigns in recent weeks targeted Indian vaccine makers Serum Institute of India (SII) and Bharat Biotech, cyber intelligence and threat discovery platform Cyfirma said on Monday.

• 

  Ministers decided to avail paid COVID vaccination facility: RS Prasad

  News | March 01, 2021 18:00 IST

  Union Minister Ravi Shankar Prasad on March 01 said that Prime Minister Narendra Modi has replied to all the people questioning that when will he get vaccinated. He further requested Opposition to unite in efforts against Corona rather than using it as a political tool.

• 

  Sister P Niveda shares her experience of administering COVID vaccine to PM Modi

  News | March 01, 2021 15:00 IST

  Prime Minister Narendra Modi took his first dose of the COVAXIN (Bharat Biotech) at Delhi's AIIMS on March 01 as the second phase of vaccination drive began in India today.

• 

  Covaxin can be modified to neutralise South African variant in 15 days: Bharat Biotech

  India | February 23, 2021 20:48 IST

  Makers of Covaxin, Bharat Biotech has said that they can modify the vaccine against coronavirus South African variant within 15 days. Bharat Biotech's developed India's own vaccine Covaxin against Covid-19 and was rolled out on January 16.

• 

  Bharat Biotech to make antigen for first-ever anti-malaria vaccine

  India | January 27, 2021 19:07 IST

  Global healthcare company GSK, non-profit agency working to end health inequity PATH, and vaccine maker Bharat Biotech on Wednesday announced the signing of a product transfer agreement for malaria vaccine RTS,S/AS01E1.

• 

  India's free vaccine supply to foreign countries begin with Bhutan, Maldives

  News | January 21, 2021 19:31 IST

  India will start supplying hundreds of thousands of doses of ‘Covishield’ vaccine on a grant basis to key neighbours beginning with 2,50,000 vaccine doses for Bhutan and Maldives. Other countries like Bangladesh and Nepal are likely to receive their supplies on Thursday.

• 

  India, a vaccine hub for the world! 92 countries request for stock

  India | January 21, 2021 16:35 IST

  Ninety-two countries have approached India for Covid-19 vaccines, bolstering New Delhi's credentials as the vaccine hub of the world.

Advertisement
• 

  Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin

  India | January 19, 2021 12:18 IST

  Out of the 45 lakh doses, the city-based vaccine maker will be supplying over eight lakh to some of the friendly countries such as Mauritius, Philippines and Myanmar, free of cost as good will gesture sources added.

• 

  Who should avoid Covaxin? Bharat Biotech issues fact sheet, warns of possible side effects

  India | January 19, 2021 12:50 IST

  Covaxin is one of the two drugs approved for emergency use in India. It is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National Institute of Virology.

• 

  8.1 lakh Covaxin doses to be procured from Bharat Biotech for other countries

  India | January 16, 2021 22:52 IST

  The Union Health Ministry on Saturday asked the Ministry of External Affairs (MEA) to consider contacting Bharat Biotech for the procurement of 8.1 lakh doses of Covaxin to be given to different countries as a goodwill gesture.

• 

  Covaxin and Covishield: All you need to know about India's COVID-19 vaccines

  India | January 16, 2021 16:29 IST

  Amid the rollout of the world's largest Covid-19 vaccination programme by Prime Minister Narendra Modi, here are a few things that you need to know about the two vaccines -- 'Covaxin' and 'Covishield' -- selected by the Drugs Controller General of India (DCGI).

• 

  Will pay compensation if Covaxin causes serious side effects: Bharat Biotech

  India | January 16, 2021 16:03 IST

  Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company will pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote.

• 

  'Indians are not guinea pigs': Congress raises question over COVAXIN's efficacy, roll out

  India | January 13, 2021 18:16 IST

  At a time when vaccine distribution to states across India is in full swing ahead of the January 16 launch, the Congress party has raised questions on the safety, compatibility of India's homegrown Covid vaccine named COVAXIN, asking the government how it can be rolled out when it is yet to clear phase-3 trials.

• 

  After Serum, Bharat Biotech’s Covaxin arrives in Delhi

  News | January 13, 2021 17:40 IST

  The first batch of Covaxin, Covid-19 vaccine by Bharat Biotech, landed at the Delhi airport from Hyderabad on Wednesday morning.

• 

  First consignment of Bharat Biotech's Covaxin reaches Delhi

  India | January 13, 2021 10:51 IST

  The first phase of the COVID-19 vaccination drive is scheduled to start from January 16. Health Secretary Rajesh Bhushan said that the Central government is having a close collaboration with states and union territories for vaccine roll-out.

• 

  Bharat Biotech inks deal to supply Covaxin to Brazil

  India | January 12, 2021 19:55 IST

  Bharat Biotech on Tuesday announced it has signed an agreement with Precisa Medicamentos for the supplies of its Covid vaccine 'Covaxin' to Brazil.